Find clinical trials for Multiple Myeloma in Barcelona, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Barcelona, CT, ESP:
This study is researching an investigational drug called linvoseltamab ("study drug") in participants at high risk of developing multiple my ...
Phase 2
Barcelona, Spain and 17 other locations
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.
Phase 1, Phase 2
Badalona, Spain and 48 other locations
Patients included in the study will receive induction treatment during 6 months, followed by receive high-dose therapy followed by peripheral blood s...
Phase 2
Barcelona, Spain and 15 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Barcelona, Spain and 31 other locations
after Intensification therapy) and safety of Tec-Dara (Teclistamab+Daratumumab) and Tal-Dara (Talquetamab+Daratumumab) in de novo high-risk multiple...
Phase 2
Barcelona, Spain and 9 other locations
of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, i...
Phase 3
Barcelona, Spain and 34 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Barcelona, Spain and 139 other locations
Multiple myeloma (MM) is a rare cancer caused by abnormal survival of plasma cells (blood cells). Most trial participants with MM r...
Phase 1
Hospitalet de Llobregat, Barcelona, Spain and 18 other locations
provide clinical benefit in participants with relapsed/refractory multiple myeloma. Elranatamab is a bispecific antibody: binding o ...
Phase 2
Barcelona, Spain and 72 other locations
phase 3 dose (RP3D) in adult participants with newly diagnosed multiple myeloma (NDMM). Participants will receive the combination o...
Phase 1
Barcelona, Spain and 29 other locations
Clinical trials
Research sites
Resources
Legal